Switch to:
More From Other Websites
Should You Get Rid of CytRx Corporation (CYTR) Now? - Tale of the Tape May 22 2015
CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma... May 21 2015
CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma... May 21 2015
10-K for CytRx Corp. May 07 2015
This Is A Near-Term Driver At CytRX May 05 2015
CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in... May 04 2015
CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in... May 04 2015
10-Q for CytRx Corp. May 03 2015
CytRx Reports First Quarter 2015 Financial Results May 01 2015
CytRx reports 1Q loss May 01 2015
CytRx reports 1Q loss May 01 2015
CytRx Reports First Quarter 2015 Financial Results May 01 2015
CYTRX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or... May 01 2015
CytRx Announces Publication of Glioblastoma Clinical Case Study in Journal of Nuclear Medicine &... Apr 29 2015
CytRx Announces Publication of Glioblastoma Clinical Case Study in Journal of Nuclear Medicine &... Apr 29 2015
GenSpera Looks Undervalued Compared to Its Peers Apr 27 2015
CytRx Corporation (CYTR) Jumps: Stock Rises 11.3% - Tale of the Tape Apr 20 2015
8 Analyst Stocks Under $10 With Massive Upside Calls Apr 18 2015
CytRx (CYTR) Stock Rises Today Following Oppenheimer Coverage Initiation Apr 17 2015
Oppenheimer Jumps On CytRx Bandwagon Apr 17 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK